Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation

Liver Transplantation

Volumn 18, Issue 8, 2012, Pages 984-992

  Kaneku, Hugo ^a,b   O'Leary, Jacqueline G ^c   Taniguchi, Michiko ^d   Susskind, Brian M ^c   Terasaki, Paul I ^b   Klintmalm, Göran B ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TERASAKI FOUNDATION LABORATORY   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d One Lambda Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR; FEMALE; GRAFT FAILURE; HUMAN; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; BIOLOGICAL SPECIMEN BANKS; BIOPSY; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864448173     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23451     Document Type: Article

References (25)

1. Kasahara M, Kiuchi T, Takakura K, Uryuhara K, Egawa H, Asonuma K, et al. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation 1999; 67: 568-575. (Pubitemid 29114220)
2. Kozlowski T, Rubinas T, Nickeleit V, Woosley J, Schmitz J, Collins D, et al. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl 2011; 17: 357-368.
3. Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M,. Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int 2010; 23: 858-859.
4. Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11: 500-510.
5. O'Leary JG, Kaneku H, Susskind BM, Jennings LW, Neri MA, Davis GL, et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant. Am J Transplant 2011; 11: 1868-1876.
6. McKenna RM, Takemoto SK, Terasaki PI,. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326. (Pubitemid 30118107)
7. Terasaki PI, Cai J,. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008; 86: 377-383.
8. Karuppan SS, Ohlman S, Möller E,. The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes. Transplantation 1992; 54: 839-844.
9. Griffiths EJ, Nelson RE, Dupont PJ, Warrens AN,. Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival. Transplantation 2004; 77: 1771-1773. (Pubitemid 38780549)
10. Hönger G, Hopfer H, Arnold ML, Spriewald BM, Schaub S, Amico P,. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011; 92: 41-47.
11. Gao ZH, McAlister VC, Wright JR Jr, McAlister CC, Peltekian K, MacDonald AS,. Immunoglobulin-G subclass antidonor reactivity in transplant recipients. Liver Transpl 2004; 10: 1055-1059. (Pubitemid 39232761)
12. Taniguchi M, Terasaki PI, Rebellato LM, Kobayashi T, Catrou PG, Briley KP,. The presence and strength of IgG3 subclass is associated with graft function in DSA-positive kidney transplant patients [abstract]. Am J Transplant 2011; 11 (suppl 2): 165.
13. Rerolle JP, Pauthier H, Essig M, Drouet M, Lacour C, Allard J, et al. DSA IgG subclasses analysis in renal transplantation: IgG3 subclass is predictive of poor allograft outcome [abstract]. Am J Transplant 2011; 11 (suppl 2): 165.
14. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792-799. (Pubitemid 30118655)
15. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705-715. (Pubitemid 16008843)
16. Moore SB, Wiesner RH, Perkins JD, Nagorney DM, Sterioff S, Krom RA,. A positive lymphocyte cross-match and major histocompatibility complex mismatching do not predict early rejection of liver transplants in patients treated with cyclosporine. Transplant Proc 1987; 19 (pt 3): 2390-2391.
17. Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400-406.
18. Ogura K, Terasaki PI, Koyama H, Chia J, Imagawa DK, Busuttil RW,. High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients. Clin Transplant 1994; 8 (pt 1): 111-115. (Pubitemid 24105401)
19. Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Elola-Olaso AM, Calleja-Antolin SM, et al. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl 2008; 14: 554-562. (Pubitemid 351524413)
20. Hori T, Uemoto S, Takada Y, Oike F, Ogura Y, Ogawa K, et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010; 147: 840-844.
21. Kushihata F, Watanabe J, Mulder A, Claas F, Scornik JC,. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004; 78: 995-1001. (Pubitemid 39391860)
22. Hirohashi T, Chase CM, Della Pelle P, Sebastian D, Alessandrini A, Madsen JC, et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012; 12: 313-321.
23. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331: 1110-1115.
24. Wiesner RH, Batts KP, Krom RA,. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transpl Surg 1999; 5: 388-400. (Pubitemid 29437016)
25. Männistö T, Surcel HM, Bloigu A, Ruokonen A, Hartikainen AL, Järvelin MR, et al. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem 2007; 53: 1986-1987.